In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 3 May 2022
Author/s

author: Barbara Michalik  Kornelia Hasse-Lazar  Beata Jurecka-Lubieniecka  Ewa Paliczka-Cieslik  Daria Handkiewicz-Junak  Aleksandra Syguła  Aleksandra Ledwoń  Barbara Jarząb  Ewa Chmielik 

Publication date May 3, 2022
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item